American biopharmaceutical giants Pfizer (NYSE: PFE) and Amgen (NASDAQ: AMGN) reported mixed fourth-quarter financial results on Tuesday. Amgen Q4 earnings and revenue exceeded Wall Street estimates while Pfizer earnings miss alongside better-than-expected revenue.
"The board will not increase the cash rate until actual inflation is sustainably within the 2 to 3% target range,” RBA said. RBA decided to keep the official cash rate unchanged at 0.10% and has expanded its quantitative easing program by purchasing an additional $100 billion of bonds.
The retail sales in Germany plunged 9.6% December of 2020 due to the stricter restrictions and lockdown measures, compared to a 2.6% drop in November.
Germany reported fourth-quarter GDP numbers on Friday, the data showed the German economy expanded 0.1% during the last quarter, compared to the expectations of 0%.
European stocks plunged as the vaccine row between the European Union and AstraZeneca Plc continued to weigh regarding the company’s failure to meet a target to deliver 400 million doses of its COVD-19 vaccine to the regional bloc.